Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Enlivex Therapeutics Ltd. (ENLV)

  • Business News
  • Nov. 25, 2025, 16:58 UTC
  • 13
  • 1 comments

Enlivex, RAIN 토큰 축적 통한 세계 최초 예측시장 디지털 자산 재무전략 위해 2억 1200만 달러 사모투자 및 Matteo Renzi 이탈리아 전 총리 이사진 합류 발표

Market reaction Comment Full text

Eastman Chemical Company (EMN)

  • Business News
  • Nov. 25, 2025, 16:45 UTC
  • 7
  • 1 comments

Eastman Chemical Company - Eastman CFO Willie McLain to address the Citi Basic Materials Conference

Market reaction Comment Full text

Eastman Chemical Company (EMN)

  • Business News
  • Nov. 25, 2025, 16:45 UTC
  • 13
  • 1 comments

Eastman CFO Willie McLain to address the Citi Basic Materials Conference

Market reaction Comment Full text

Phio Pharmaceuticals Corp. (PHIO)

  • Business News
  • Nov. 25, 2025, 16:30 UTC
  • 10
  • 1 comments

Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762

Market reaction Comment Full text

Smart for Life, Inc. (SMFL)

  • Business News
  • Nov. 25, 2025, 15:20 UTC
  • 18
  • 1 comments

Creating Connections With CCASE and the Springfield Technical Community College Affiliate

Market reaction Comment Full text

AbbVie Inc (ABBV)

  • Business News
  • Nov. 25, 2025, 14:30 UTC
  • 13
  • 1 comments

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec

Market reaction Comment Full text

AbbVie Inc (ABBV)

  • Business News
  • Nov. 25, 2025, 14:30 UTC
  • 18
  • 1 comments

Lancement du Prix AbbVie des innovateurs en biotechnologies au Québec : AbbVie et adMare BioInnovations encouragent l’innovation dans le domaine des sciences de la vie

Market reaction Comment Full text

Allurion Technologies Inc (ALUR)

  • Business News
  • Nov. 25, 2025, 14:25 UTC
  • 15
  • 1 comments

Allurion - Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

Market reaction Comment Full text

Allurion Technologies Inc (ALUR)

  • Business News
  • Nov. 25, 2025, 14:25 UTC
  • 16
  • 1 comments

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

Market reaction Comment Full text

PharmaCyte Biotech Inc. (PMCB)

  • Business News
  • Nov. 25, 2025, 14:15 UTC
  • 17
  • 1 comments

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Market reaction Comment Full text
  • Previous
  • 514
  • 515
  • 516
  • 517
  • 518
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin